Such are the effects and injuries from supervoltage irradiation as we have seen them at St. Bartholomew's. The injuries, because of their relative rarity, have been described in some detail, and if any defence is demanded for the methods which have unfortunately produced them, one can only reiterate the Hippocratic aphorism of "extreme methods of cure for extreme diseases". (5) Carcinoma of the oesophagus-thus continuing a research into the results of X-ray therapy in malignant disease commenced in 1924 and elaborated in 1931. The research was, however, handicapped by the war; Mr. Ralph Phillips was the only therapist left in the hospital, and his time had to be divided between the million-volt and deep-therapy departments. Allocation of patients became dictated by the capacity of each department, and for humanitarian reasons patients not falling into the five groups were accepted for millionvolt therapy. It has been the policy at St. Bartholomew's Hospital to treat early malignant disease by surgical rather than radiotherapeutic methods, if experience is favourable as judged by end-results. Thus patients referred for million-volt therapy were incurable by any other means, either because of the nature of the tumour, its anatomical extent or the general condition of the patient. Less than 5 % of the total number fall into the early operable group. I think the tables are valuable as an indication of what we can and cannot do for our patients, in the conditions or stages in which they come to us for treatment. Our experience emphasizes clearly that early disease can be cured, that late disease cannot be cured, but that we can offer considerable palliation.
Million-Volt X-ray Therapy By I. G. WILLIAMS, F.R.C.S., D.M.R.E. THIS report analyses the results of the treatment of malignant disease by means of X-rays generated at one million volts. As a primary research, five main sites were chosen: (1) Carcinoma of the breast, inoperable but without distant metastases.
(2) Carcinoma of the cervix in all stages of the disease. (3) Cancer of the upper air and food passages. (4) Inoperable carcinoma of the rectum. (5) Carcinoma of the oesophagus-thus continuing a research into the results of X-ray therapy in malignant disease commenced in 1924 and elaborated in 1931. The research was, however, handicapped by the war; Mr. Ralph Phillips was the only therapist left in the hospital, and his time had to be divided between the million-volt and deep-therapy departments. Allocation of patients became dictated by the capacity of each department, and for humanitarian reasons patients not falling into the five groups were accepted for millionvolt therapy. It has been the policy at St. Bartholomew's Hospital to treat early malignant disease by surgical rather than radiotherapeutic methods, if experience is favourable as judged by end-results. Thus patients referred for million-volt therapy were incurable by any other means, either because of the nature of the tumour, its anatomical extent or the general condition of the patient. Less than 5 % of the total number fall into the early operable group. I think the tables are valuable as an indication of what we can and cannot do for our patients, in the conditions or stages in which they come to us for treatment. Our experience emphasizes clearly that early disease can be cured, that late disease cannot be cured, but that we can offer considerable palliation. 726 cases are available for study, no case has been eliminated and the figures are absolute values for those referred. We have been unable to trace a few of our patients, and these are counted as dead. As radiotherapists I believe we tend to over-emphasize our survival statistics. True, we have to present our successes as survival rates in order to compare with other forms of treatment or combined treatments, so as to give the patients the best possible chance of survival. But let us not lose sight of the degrees of palliation we can offer, the relief of physical and mental pain and distress, which cannot be recorded in graphs or statistics. When one remembers that less than to be unsuitable and difficult for 200 kV therapy. A dose of 4,500 r can be delivered evenly to the chest wall, axilla and supraclavicular region in four to five weeks. This results in a brisk second-degree reaction which heals with fibrosis and later telangiectasia. There were no cases of pulmonary fibrosis resulting from treatment, but one patient developed a necrosis of the clavicle, and one patient has a fibrosis of the pectoral muscles, with a brachial neuritis, similar to the ones we used to get following radium implantation. Clinically, the primary tumour as well as large glandular metastases may disappear completely and histological examination of breasts removed after irradiation has shown either no recognisable carcinoma or degenerate carcinoma in fibrosed tissue. I can confirm Phillips' observation that disappearance of the primary tumour and regional lymphatic metastases is more certainly and more easily obtained with supervoltage than with deep X-ray therapy. These were patients with advanced primary disease, together with glandular metastases, unilateral and fixed, or bilateral. In 6 patients the primary growth regressed, without recurrence before the patient died from metastases. In 2 patients death was due to exhaustion and pulmonary metastases. In 8 patients, although some initial response was obtained in large. glandular metastases, they rapidly recurred and extended. Mucosal reactions are severe with supervoltage, due to the large depth dose which can be delivered for a safe skin reaction. In spite of this, no difference was noted between those treated by million-volt therapy and deep X-ray therapy. Technically, however, it is easier to deliver the dose by million-volt therapy as an even distribution can be achieved by means of two opposing and parallel fields.
Carcinoma of the Antrum (1939 Antrum ( -1945 .
Total number of cases 20. Primary 13. Recurrent (following other forms of treatment) 7. All the cases with recurrent disease died within twelve months of treatment.
Survival (13 cases All patients had advanced primary disease. The average dose has been 4,500 r in twenty-one days through two oblique and opposed fields. The eye was included in an irradiated field in most patients and three out of four survivors have eye damage in the form of a radiation cataract. One of these has also a troublesome conjunctivitis and iritis, but apart from dimness of vision the other two are free of symptoms. Primary reactions are severe, but ultimate healing is good. The antrum-has been explored in all, following therapy. Afterwards, all seem to have experienced some pain whilst dead bone was separating, but once this happened, pain was relieved, and with the fitting of an obturator they have been quite comfortable. The results are an improvement on ordinary deep X-ray therapy alone. Extrinsic Carcinoma of the Larynx This group includes growths of the pyriform fossa, aryepiglottic fold, epiglottis and pharyngeal wall. In two the primary was so large that the origin could not be determined. All the patients who died, died of their disease. In a few, large fixed masses became impalpable but they soon recurred, within the treated area. Of the three survivors, one had a carcinoma of the pyriform fossa with direct infiltration of the neck at the level of the primary. He is well with a strong voice, with slight persistent aedema following a tumour dose of only 3,000 r in fourteen days. In a second, the primary tumour was so large the origin could not be determined until it regressed. It was then thought to arise from the epiglottis. He also had hard mobile glands in the neck. The recurrent cases were following fenestration and radium or surgical removal. Some palliation was achieved, but these died of disease; in one case growth was spreading and fungating in the irradiated area. One case survives five years: Male, 56. 1941 . Laryngo-fissure removal of left and anterior part right cord. 6/12 later hemilaryngectomy for recurrence. 2/12 later, post-operative deep X-ray therapy, 3,500 r in seventeen days. One year later, 1943, subglottic recurrence treated on million volt, 4,000 r in nineteen days. Remains well and free of recurrence to date (five years).
Most were treated through two opposing fields, either anteroposterior or lateral, the inequalities of the neck being filled up with bolus. "Dose" varied from 3,000 r in fourteen days to 6,000 r in thirty days. One patient with a well-differentiated squamous-cell carcinoma involving the whole of one fixed cord, and a hard lymph node in the neck, is alive and well five years after treatment, 3,000 r having been delivered to the tumour in ten days. Another patient, treated up to 4,500 r in twentyseven days, developed a recurrence in the third year, on the cord. He had a laryngectomy, section of the cord being positive for carcinoma. Two cases in Stage 2 died from undoubted other causes (both were old and feeble) without any laryngeal symptoms. Another developed a local recurrence on the cord, four years after a dose of 5,600 r in twenty-eight days, delivered to the cord. He had so much fibrosis cedema and skin changes that further treatment was not possible, either surgery or radiotherapy.
Three other patients died from perichondritis and cedema within a few weeks of tracheotomy.
On the assets side, however, in 5 of the patients an absolutely fixed cord became mobile, and these survive.
Carcinoma of the GEsophagus The patient who survived had an early squamous-cell carcinoma in the postcricoid region. 5,000 r was delivered in forty-six days, and apart from telangiectasia of skin and laryngeal mucosa she remains well, swallowing normally four years later.
Analysis ofpatients who died
At months Alive Dead At months Alive  Dead  6  11  3  24  5  0  12  7  4  30  3  2  18  5  2  36  2  1  48  0  2 Ad In all these dysphagia was relieved for varying periods of time, but later returned. Tumour dose varied from 4,500 r in sixteen days to 6,000 r in thirty-five days with an average of 5,000 r in twenty-eight days. 5 patients developed a local recurrence in the post-cricoid region, after doses of 4,500 to 5,000 r. All developed lymph-node metastases and 3 died from disseminated neoplasm. 4 patients had to have tracheotomy because of laryngeal obstruction due to oedem'a, and 2 of these, gastrostomy as well. The doses of radiation delivered are probably-the maximum the tissues in this region can tolerate in this period of time.
(2) Carcinoma of the (esophagus proper- The average tumour dose has been 5,000 r in thirty days, delivered through six strip fields. Those patients treated up to 6,000 r in thirty-six to forty days did no better than those where only 4,000 r was given in twenty-eight days. In most patients dysphagia was relieved until the death of the patient. Apart from metastases, other causes of death were perforation of the cesophagus into the mediastinlium, great vessels or lung. Some died suddenly of heart failure, and at post-mortem growth was found invading the heart muscle. 5 patients died suddenly following a sudden severe hemorrhage, and in one of these at post-mortem there was no sign of growth, but the aorta and cesophagus communicated through a large smooth opening. There was no mediastinitis and no sign of X-ray necrosis above and below the aortic perforation. This particular case received a dose of 5,500 r in thirty-five days, and Phillips suggested that in these the appearances point to a failure on the part of the normal tissues to repair the gap left by the destruction of the carcinoma, so that the question ofcure in carcinoma of the cesophagus appears to be less one of radiation dosage, than of tissue healing under adverse conditions. However, in at least 5 patients local recurrence of growth developed at the primary site, in 2 within six months, in 2 within twelve months and in 1 twenty-four months after treatment.
In 2 patients who died and on whom a post-mortem was performed, the pathologist was unable to find evidence of carcinoma. One death was from a perforation into the aorta and one from pneumonia.
Six patients died with extensive metastases in chest, liver, abdomen and spine. Carcinoma of the Bronchus Of the 2 patients who are alive:
(1) Woman, 46. 1943: Left pneumonectomy. The growth, a squamous-cell carcinoma, involved left pulmonary vein, and stump of this was left behind, together with growth on the pericardium.
Well and active five years.
(2) Man, 57. Alive four years, free of clinical evidence of carcinoma. He has extensive pulmonary fibrosis, with a flat chest and scoliosis, the heart is drawn over. He has a cough, purulent sputum, some pain and marked dyspncea.
The average tumour dose given has been 4,000 r in twenty-eight days, the maximum received being 5,000 r in fifty days.
Many cases were advanced when first seen and the general condition poor; they were ill patients, thin and wasted. Out of the 146, 59 had metastases when first seen, many had massive opacities and no attempt was made at selection. The length of history was short, the average being under six months, suggesting that carcinoma of the bronchus is a highly malignant cancer leading to cachexia sooner than most tumours. Although the oat-cell carcinoma appears the most sensitive type as judged by the radiological evidence of response, no marked prognostic difference was found between this growth and the squamous-cell variety. The average duration of symptoms in each was six months, and the average survival after treatment nine to nine and a half months. In carcinoma of the bronchus as it comes to us, 500% of treated patients are dead in six months, 75 % in twelve months, and about 90 to 95% in two years. As Phillips noted, the problem is not entirely one of dosage, for cases treated to high dosage have done no better than those given a lower dose. Relief of symptoms is real, in most haemoptysis will cease, and cough and dyspncea are relieved, as a blocked bronchus reopens. In some, recurrence of growth occurred at the primary site, following heavy irradiation, and death was due to the effects of the primary tumour. Those patients who died within six months of treatment derived a little benefit, such as relief of haemoptysis, or of spasms of dyspnoa, In very few was there no effect at all, but return of symptoms was rapid. In those that survived up to twelve to twenty-four months the initial response was greater, and some died of cerebral or bony metastases without return of chest symptoms, but in the large majority pain and cough returned, although haemoptysis was controlled. One patient returned to heavy manual work for eighteen months. Of the 13 that survived over two years, 3 remained weak and poorly, but 10 regained almost normal health for twelve to twenty-four months, and then died from metastases with return of pains in the chest and cough. Carcinoma of the Bladder (1) Recurrent disease.-These patients had advanced disease, invading abdominal wall, rectum, &c. 4 died, the average survival being six and a half months. One is alive four and a half years after treatment: Man, aged 70. 1936 Man, aged 70. , partial cystectomy. 1941 , recurrence-large sessile papilloma-fulgurated. Six months later, further recurrence. H.V. X-rays, 5,000 r in fifty-two days to the bladder. Two years later, 1943, further recurrence treated by H.V. X-rays to 5,000 r in forty-two days. He remains well to date (four and a half years).
(2) Malignant ulceration with infiltrating carcinoma.-All these 8 patients are dead, average survival being eight months. 2 patients died of other causes and at postmortem no microscopic evidence of growth could be found. 2 further patients died from metastases with controlled primary disease. In 4 patients the primary growth was not affected.
(3) Malignant papilloma.-This forms the largest group, 7 out of 22 patients having survived for periods from two to five years. All had extensive bladder involvement-15 patients had had repeated fulgurations either cystoscopically or through open cystotomy for varying periods of time up to twelve years previously, the average being four years. 7 were new patients treated primarily by radiotherapy. 7 out of the 22 are alive and well, and 5 of these are nearing their fifth anniversary since treatment. They are symptom free.
Of those that died, 5 developed extensive papillomatous recurrences in the bladder following doses of 4,000 r and 5,000 r, one three months and one twenty months after treatment. In 2 of these there was no appreciable effect on the primary growthsbut all had marked relief of hematuria.
In only one case is there evidence of severe damage to the bladder due to the treatment. One patient developed a desquamative cystitis following 4,500 r in six days which persisted and necessitated a total cystectomy. He died twenty months later from metastases. Of the survivors, 3 had fixed inoperable lymph-node metastases in the groins, one had a large necrosis, another a small, dry, symptomless necrosis, whilst 2 have anal strictures, in both precluding the closure of a colostomy. One developed a local recurrence in the primary site and he had to have a perineo-abdominal excision.
Dead.-15 are dead, 10 dying in the first year after therapy. 12 were old and feeble, in poor general condition. In 7 the primary growth regressed completely and they died from metastases. One died five and a half years after treatment from a cerebral hxmorrhage, without local or metastatic disease.
Five patients had a serious radiation necrosis, probably responsible for the death of one. In only one of these did healing occur before death. One of these had further deep X-ray therapy at another hospital, whilst a second had radium applied. Both of these developed huge necroses. Carcinoma Four patients died in their second year from undoubted other causes, with controlled carcinoma of the rectum and symptom free. Two survived two and three years, without colostomy and died from heart failure.
In 420% there was complete relief of symptoms due to the primary growth and 600% were quite comfortable. In many this can be long-lasting and they die from metastases. Some of these did not need a colostomy, although following, therapy there may be so much fibrosis that a stricture results and this may call for colostomy. In 52 out of 118 patients (weeded from the mass because radiotherapy did have a chance) the notes read "relief of pain, no discharge P.R., no symptoms due to the primary growth". Some striking results have been obtained.
(1) Woman, aged 41. Laparotomy (1938) . Fixed inoperable carcinoma of the rectum. Adenocarcinoma. Glandular metastases present in the pelvis. H.V. X-ray therapy. 5,000 r in thirty-nine days. Three years later colostomy closed. Alive and very well ten years later. Slight stricture at site of primary and she has an irritable bladder, with telangiectasia of the mucosa, but is'quite comfortable.
(2) A doctor with a metastasis in his liver (laparotomy) lived for eighteen months, for fifteen of which he ran a busy practice, symptom free.
A number retumed to heavy manual work, symptom free and died eventually from metastases.
Recurrent disease Three patients are worth recording in detail.
(1) Man, aged 35. Huge recurrence in the stump of a Hartmann's operation. Lived four years for three and a half of which he was at full work.
(2) Man, aged 55. With perineal and ischiorectal nodules and fixed inguinal metastases, returned to full work for two and a half years and then died of deeper metastases.
(3) Man, aged 31. Abdomino-perineal excision in Cairo. One year later fungating metastatic growth around colostomy. Transverse colostomy done-he is alive, well and at full work five years later.
The average survival of those that died was 16-8 months. For colostomy alone the figure in the literature is 16-9 months, but I believe that patients treated by radiotherapy are more comfortable than those treated by colostomy alone, for tenesmus and discharge are lessened or abolished.
Cancer in Various Sites
We have, of course, treated a few cases of malignant disease in most sites. We can all show some cases of dramatic effects of radiation therapy and long survivals. In this group of cancer in various sites I would like to make the following remarks:
( One was a fungating sarcoma of the tibia in a child. There was marked regression following irradiation. Amputation was performed and she remains well ten years later. I have treated one case of osteogenic sarcoma with a marked effect (sclerosis) on the primary, but nine months later he has multiple pulmonary metastases. (1) Those tumours that respond poorly to ordinary X-ray therapy show no very marked differences in response to million-volt therapy, with the possible exception of carcinoma of the rectum, carcinoma of the bladder, carcinoma of the antrum and carcinoma of the larynx.
(2) There is no evidence of any biological difference in response due to the shorter wavelength used.
(3) The question of dosage remains obscure. For instance, many tumours recurred in the treated area following heavy irradiation, others were arrested by 3,000 r in fourteen to twenty-one days.
(4) Any improvement in results is, I believe, due to the physical advantages of greater penetration, and greater accuracy due to ease of application, i.e. the treatment is more efficient.
(5) As Holmes and Leucutia have pointed out, "there is no quality dependence in that neoplasms that fail to respond to deep roentgen therapy can be destroyed by high voltage therapy".
It is a pleasure for me to acknowledge my debt and my gratitude: 
